Jump to main content
博士論文

Efficacy and safety of repaglinide added to sitagliptin in Japanese patients with type 2 diabetes: A randomized 24-week open-label clinical trial

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

Efficacy and safety of repaglinide added to sitagliptin in Japanese patients with type 2 diabetes: A randomized 24-week open-label clinical trial

Persistent ID (NDL)
info:ndljp/pid/11099139
Material type
博士論文
Author
西村, 明洋
Publisher
東邦大学
Publication date
2017-03-28
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
東邦大学,博士(医学)
View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii DissertationsLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Notes on use

Note (General):

type:Doctor Thesis主査 : 龍野一郎 / タイトル : Efficacy and safety of repaglinide added to sitagliptin in Japanese patients with type 2 diabetes: A randomized 2...

Table of Contents

Provided by:国立国会図書館デジタルコレクションLink to Help Page
  • 2023-12-08 再収集

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Author/Editor
西村, 明洋
Author Heading
Publication, Distribution, etc.
Publication Date
2017-03-28
Publication Date (W3CDTF)
2017-03-28
Alternative Title
レパグリニドとシタグリブチン併用の有効性および安全性の比較検討:ランダム化24 週非盲検試験
Periodical title
東邦大学大学院医学研究科 博士論文
Degree grantor/type
東邦大学